MedTrace Logo

Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®

NCT00806897 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 74

Last updated 2016-11-23

No results posted yet for this study

Summary

This study is conducted in Europe. The aim of this observational study is to gain practical experience with once daily Levemir® administration in type 2 diabetes patients who were previously treated with NPH insulins (e.g. Protaphane®) as basal insulin as part of their IIT under normal clinical practice conditions in Lithuania

Conditions

Interventions

DRUG

insulin detemir

Effectiveness data collection in connection with the use of the drug Levemir® in daily clinical practice.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-01-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • Lithuania

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00806897 on ClinicalTrials.gov